Cullinan Therapeutics (CGEM) FCF Margin (2021)

Historic FCF Margin for Cullinan Therapeutics (CGEM) over the last 1 years, with Q1 2021 value amounting to 8.0%.

  • Cullinan Therapeutics' FCF Margin changed N/A to 8.0% in Q1 2021 from the same period last year, while for Dec 2021 it was 229.28%, marking a year-over-year change of. This contributed to the annual value of 229.28% for FY2021, which is N/A changed from last year.
  • As of Q1 2021, Cullinan Therapeutics' FCF Margin stood at 8.0%.
  • Cullinan Therapeutics' FCF Margin's 5-year high stood at 8.0% during Q1 2021, with a 5-year trough of 8.0% in Q1 2021.